Profil
Dakota Gallivan est Chief Healthcare Compliance Officer & VP chez Reata Pharmaceuticals, Inc. M. Gallivan occupait auparavant le poste de Compliance Counsel chez Pharmacyclics LLC. M. Gallivan a obtenu un diplôme de premier cycle au St. Francis College et un diplôme de deuxième cycle à la Seton Hall University School of Law.
Anciens postes connus de Dakota Gallivan
| Sociétés | Poste | Fin |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Compliance Officer | 26/09/2023 |
| DERMIRA, INC. | General Counsel | 01/01/2020 |
| PHARMACYCLICS, INC. | General Counsel | 01/04/2018 |
| Medivation, Inc. /Old/ | General Counsel | 01/04/2017 |
| PFIZER, INC. | General Counsel | 01/04/2017 |
Formation de Dakota Gallivan
| St. Francis College | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
